Captodiame hydrochloride
- Level
- Commodity
- Parent
- 51401700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401707This classification denotes an anxiolytic with the molecular formula C21H29NS2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9I7N9PR9J2, chemically known as 2((p-(butylthio)-alpha-phenylbenzyl)thio)-n,n-dimethylethylamine hydrochloride but more generally known as captodiame hydrochloride, which bears US NIH Compound Identifier 13484. European Medicines Agency schedules Captodiame hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01035MIG. Most nations, for tariff and trade purposes, schedule captodiame hydrochloride under HS 29309085. As of Q4 2014, CAPTODIAME HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Captodiame hydrochloride bears US NLM identifiers UMLS ID C2698983 and NCI Concept Code C76504. SMILES: CCCCSC1CCC(CC1)C(C2CCCCC2)SCCN(C)C.CL.
Same parent
Under 51401700 · 10Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.